GeneDx Holdings Corp. Securities Class Action Investigation

Rosen Law Firm is investigating potential securities claims on behalf of GeneDx Holdings Corp. shareholders, alleging the company may have issued misleading business information. Investors who purchased GeneDx securities may be entitled to compensation through a contingency fee arrangement. To join the prospective class action, visit https://rosenlegal.com/submit-form/?case_id=40333 or call Phillip Kim, Esq. at 866-767-3653.

Rosen Law Firm has initiated an investigation into potential securities claims against GeneDx Holdings Corp. (NASDAQ: WGS) on behalf of its shareholders. The investigation stems from allegations that GeneDx may have issued materially misleading business information to the investing public.

On February 5, 2025, Grizzly Research published a report titled "Insiders Attest that GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud." The report alleged that GeneDx's growth is largely an illusion, driven by fraudulent schemes and illegal tactics aimed at exploiting Medicaid and Medicare systems to artificially inflate revenue. Following the report's release, GeneDx's stock fell by 6.7% on February 5, 2025 [1].

Rosen Law Firm, known for its expertise in securities class actions and shareholder derivative litigation, is encouraging investors who purchased GeneDx securities to join a prospective class action. The firm is seeking recovery of investor losses through a contingency fee arrangement, meaning no out-of-pocket fees or costs are required [2].

Investors interested in joining the class action can visit https://rosenlegal.com/submit-form/?case_id=40333 or contact Phillip Kim, Esq., toll-free at 866-767-3653 for more information.

Rosen Law Firm, with a track record of success, has achieved significant settlements in securities class actions. For instance, in 2017, the firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements. The firm has recovered hundreds of millions of dollars for investors, including securing over $438 million in 2019 alone [1].

References:
[1] https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-genedx-holdings-corp-investors-to-inquire-about-securities-class-action-investigation--wgs-302529374.html
[2] https://www.marketscreener.com/news/rosen-law-firm-encourages-genedx-holdings-corp-investors-to-inquire-about-securities-class-action-i-ce7c5edddf89ff2c